The therapeutic properties of lithium ions (Li ϩ ) are well known; however, the mechanism of their action remains unclear. To investigate this problem, we have isolated Li ϩ -resistant mutants from Dictyostelium. Here, we describe the analysis of one of these mutants. This mutant lacks the Dictyostelium prolyl oligopeptidase gene (dpoA). We have examined the relationship between dpoA and the two major biological targets of lithium: glycogen synthase kinase 3 (GSK-3) and signal transduction via inositol (1,4,5) trisphosphate (IP 3 ). We find no evidence for an interaction with GSK-3, but instead find that loss of dpoA causes an increased concentration of IP 3 . The same increase in IP 3 is induced in wild-type cells by a prolyl oligopeptidase (POase) inhibitor. IP 3 concentrations increase via an unconventional mechanism that involves enhanced dephosphorylation of inositol (1,3,4,5,6) pentakisphosphate. Loss of DpoA activity therefore counteracts the reduction in IP 3 concentration caused by Li ⍣ treatment. Abnormal POase activity is associated with both unipolar and bipolar depression; however, the function of POase in these conditions is unclear. Our results offer a novel mechanism that links POase activity to IP 3 signalling and provides further clues for the action of Li ⍣ in the treatment of depression.
Introduction
Lithium is a major treatment for clinical depression and is taken by 1% of the population. It is the standard treatment for bipolar depression and is also effective against recurrent unipolar depression. It can be used in conjunction with antidepressants (Heit and Nemeroff, 1998) or as a temporary mood stabilizer between treatments (Lenox et al., 1998) . Li ϩ , however, has a small therapeutic index and a number of hazardous side effects. Overdose can lead to unconsciousness and death (Bowden, 1998) . The molecular basis of these disorders and their treatment by Li ϩ remains unknown. A strongly supported theory was proposed by Berridge et al. (1989) . In their inositol depletion theory, Li ϩ inhibits inositol monophosphatase (IMPase) and blocks the conversion of IMP
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© European Molecular Biology Organization to inositol. This causes a reduction of the free pool of inositol and ultimately lowers the cellular concentration of phosphatidyl (4,5) bisphosphate (PIP 2 ). In addition, Li ϩ inhibits the enzyme inositol polyphosphatase (IPP) which is required for the dephosphorylation of inositol (1,4) bisphosphate to IMP (Gee et al., 1988; Inhorn and Majerus, 1988) . In response to receptor stimulation, PIP 2 is cleaved by phospholipase C (PLC) to form the second messengers inositol (1,4,5) trisphosphate (IP 3 ) and diacylglycerol (DAG). These molecules cause the release of Ca 2ϩ from intracellular stores and activation of protein kinase C (PKC), respectively (Nishizuka, 1992) . Li ϩ depletion of PIP 2 therefore has the potential to cause a significant effect on signal transduction.
Although there is little doubt that Li ϩ inhibits IMPase in brain slices (Kennedy et al., 1990; Hokin, 1993 ), it has not been possible to link changes of phosphoinositide signalling directly to depression. Recently, Li ϩ has been shown to inhibit glycogen synthase kinase 3 (GSK-3) and this can account for many of its teratogenic properties (Klein and Melton, 1996) . Members of the GSK-3 family have been found in all eukaryotic groups where they mediate a wide range of cellular processes, including intermediate metabolism, gene expression and cytoskeletal integrity (Plyte et al., 1992) . In metazoa, they act within the Wnt-1 signal transduction pathway which is required for pattern formation during development. GSK-3 is abundant in brain tissue (Woodgett, 1990) and causes hyperphosphorylation of tau protein in patients with Alzheimer's disease (Mandelkow et al., 1995) . GSK-3β is also required for cytoskeletal organization during development of cerebella granule neurons (Lucas et al., 1998) . Inhibition of GSK-3 therefore presents an alternative mechanism for the treatment of depression and could certainly explain a number of Li ϩ side effects.
Dictyostelium development is sensitive to Li ϩ treatment. Dictyostelium cells grow as unicellular amoebae, but when starved enter a developmental programme. This consists of two phases: aggregation, in which amoebae form a cellular mass called the mound, and multicellular development, where the processes of differentiation and morphogenesis transform the mound to a fruiting body. This structure comprises three elements: the spore head, the stalk which supports the spore head and the basal disc into which the stalk is embedded. In addition to these three cell types, cells of the lower and upper cup form a cradle to suspend the spore head (Williams and Jermyn, 1991) . Maeda (1970) showed that treatment with 7 mM LiCl causes the formation of a mis-proportioned fruiting body, in which the spore head is almost completely lost and the base is expanded into a mound of stalk cells. This morphology is likely to arise by inhibition of GSK-3, as it is also seen in a mutant which lacks gskA, the Dictyostelium GSK-3 homologue (Harwood et al., 1995) , and arises due to mis-specification of the pre-spore and pre-stalk B cell types . Treatment of wild-type cells with higher concentrations of LiCl blocks aggregation. This phenotype is not associated with loss of gskA and suggests that other targets of Li ϩ are important for development (Maeda, 1970) .
To investigate the molecular basis of Li ϩ action, we have generated Li ϩ -resistant mutants in Dictyostelium. Analysis of these mutants offers a unique opportunity to dissect the effects of Li ϩ on GSK-3 and IP 3 signalling. Here we describe one of these mutants, in which the Dictyostelium prolyl oligopeptidase (dpoA) is disrupted. This mutant has elevated IP 3 concentrations and consequently escapes Li ϩ inhibition of IMPase. The interaction revealed in these studies relates directly to observations made on patients with depression, and suggests a mechanism that could explain both cause and treatment of depression.
Results

Generation of Li ⍣ -resistant mutants
Exposure to 10 mM LiCl severely retards aggregation of Dictyostelium cells ( Figure 1A and B). In most cases, however, aggregation is not totally blocked and will occur after a prolonged period of time. The effect of Li ϩ is reversible and cells will form a wild-type fruiting body when Li ϩ is removed ( Figure 1C ). Cells are sensitive to Li ϩ throughout development, suggesting that Li ϩ inhibits processes which are required at all developmental stages. Li ϩ is also effective on cells grown in association with bacteria. Clonally plated cells multiply on a bacterial lawn Fig. 1 . Comparison of lithium sensitivity of wild-type and dpoA mutants. Cells (1ϫ10 7 ) were plated in KK 2 buffer onto nitrocellulose membranes and developed for 40 h. Aggregation in wild-type Dictyostelium is not affected by 10 mM NaCl (A), but is impeded by 10 mM LiCl (B). Cells treated with 10 mM LiCl for an initial 6 h of development aggregate normally when lithium is removed (C). dpoA mutant cells aggregate and form fruiting bodies in either 10 mM NaCl (D and F) or 10 mM LiCl (E and G). Lithium-treated dpoA mutant cells, however, have an enlarged basal disc and reduced spore head as also seen with a gskA mutant (G). Aggregation of dpoA mutant cells is not affected by 20 mM NaCl (H), but is sensitive to 20 mM LiCl (I). Mixing wild-type and dpoA cells (1:10 respectively) does not induce loss of lithium resistance in the dpoA mutant cells (J). Mixtures of wild-type cells expressing β-galactosidase (stained) and dpoA cells (1:10 respectively) aggregate normally in 10 mM NaCl (K), and wild-type cells are not included in fruiting bodies in the presence of 10 mM LiCl (L) at 16 h. Bar ϭ 0.5 mm.
to form a plaque where the cells in the centre starve and develop. When plated in these conditions in the presence of 10 mM LiCl, wild-type cells grow but aggregate poorly and form plaques with few developed structures. The ability to develop in these conditions was used in a genetic screen to isolate mutants resistant to the effects of Li ϩ .
From a screen of 30 000 mutagenized cells, 13 mutants were isolated that could aggregate well in 10 mM LiCl. Eleven of these mutants showed morphological defects during later developmental stages in the presence of LiCl, but in its absence all but two could develop fruiting bodies with a wild-type morphology. Here we describe our analysis of one of the genes identified from this screen, denoted as dpoA. The dpoA mutant aggregates in 10 mM LiCl but forms abnormal fruiting bodies ( Figure 1D -G). Treatment with 10 mM NaCl has no effect on the development of either wild-type or the dpoA mutant cells ( Figure 1A, D and F) . Aggregation of the dpoA mutant, however, is retarded at higher Li ϩ concentrations, suggesting that it has reduced sensitivity rather than complete resistance to Li ϩ ( Figure 1H and I). Mixing wild-type and dpoA mutant cells in a ratio of 1:10 does not restore Li ϩ sensitivity to dpoA mutant cells nor does it confer Li ϩ resistance to wild-type cells ( Figure 1J , K and L).
To confirm the effects of Li ϩ on early development, the expression of the gene for contact site A (csA) was examined ( Figure 2A ). This gene is expressed during aggregation in response to pulses of extracellular cAMP (Siu et al., 1988) . CsA protein was expressed in wildtype cells after 6 h of development in shaking culture. Addition of 10 mM LiCl completely inhibits csA expression. Expression is not rescued by addition of cAMP pulses ( Figure 2B ), indicating that Li ϩ blocks the cellular response to cAMP. The dpoA mutant expresses csA in the presence of 10 mM LiCl. The dpoA mutant also expresses csA during growth, suggesting that the mutant may initiate development prematurely. dpoA mutant cells grow on bacteria or when plated in medium on tissue culture plates; however, the same cells are unable to sustain prolonged growth in suspension culture (data not shown). The basis of the effect on cell growth is not known. dpoA encodes a prolyl oligopeptidase The original dpoA mutant was generated by insertional mutagenesis using REMI (Kuspa and Loomis, 1992) , and a genomic fragment of the dpoA gene was cloned by plasmid rescue. The rescued plasmid was used to disrupt the dpoA gene of wild-type cells to confirm that its loss results in Li ϩ resistance. The recreated dpoA mutant strains had exactly the same phenotype as the original strain and were used in all subsequent experiments. Both the genomic fragment and its corresponding cDNA were sequenced and found to encode a prolyl oligopeptidase enzyme (POase; Figure 3A and B). The name dpoA derives from Dictyostelium prolyl oligopeptidase. The dpoA cDNA contains an open reading frame of 760 amino acids which shows 41% identity to its human homologue (Shirasawa et al., 1994; Vanhoof et al., 1994) . The highest homology occurs within the C-terminal third of the gene, and this region contains the amino acid triad (Ser-AspHis) that is essential for enzymatic activity ( Figure 3C ; Goossens et al., 1995) . The gene contains a single intron of 82 bp. The dpoA mutant results from a plasmid insertion into the 5Ј region of the coding sequence and is likely to cause a complete loss of DpoA protein ( Figure 3B ). The human POase enzyme cleaves neuropeptides, some of which may be involved in the pathophysiology of depression (Cunningham and O'Connor, 1997) . This function and the recent report that abnormal POase activity is a state marker for both unipolar and bipolar depression (Maes et al., 1995) prompted a detailed analysis of the dpoA gene.
DpoA activity was examined in wild-type and dpoA mutant cell extracts. Z-Gly-Pro-pNA (ZGPpNA) is a Fig. 2 . Lithium inhibits csA expression in wild-type but not the dpoA mutant. Western blot with anti-csA monoclonal antibody against Dictyostelium cell extracts. (A) Wild-type and dpoA whole cell extracts from growing cells (-) and cells starved for 6 h with 10 mM NaCl or 10 mM LiCl. (B) Wild-type whole-cell extracts from cells developed for 6 h in the presence of cAMP (300 nM pulses, every 6 min) with 10 mM NaCl or 10 mM LiCl. specific substrate of POases and is cleaved in wild-type extracts ( Figure 4A ). The K m of this reaction compares well with that measured for other POase enzymes (Table  I) . POase activity is completely absent in the dpoA mutant ( Figure 4A ), suggesting that DpoA is the only POase in Dictyostelium during growth and development. POase enzymes are serine hydrolases and consequently are inhibited by chymostatin through a non-competitive mechanism. The same non-competitive inhibition is observed when DpoA is incubated with chymostatin (K i ϭ 12.0 Ϯ 2.3 μg/ ml). BOC-Glu(NHO-Bz)-Pyr is a competitive inhibitor of the proline-specific endopeptidase enzyme group including POase. DpoA is competitively inhibited by BOCGlu(NHO-Bz)-Pyr with a K i comparable with that of mammalian POase (Table I ). Finally, we tested DpoA against the inhibitors Z-Pro-L-prolinal dimethyacetal and the peptide H-H-L-P-P-P-V-OH, which specifically target POase. Both of these inhibit DpoA activity (Table I) . These results indicate that the biochemical properties of DpoA are typical of the POase enzyme family.
Localization of DpoA activity
To examine whether DpoA is secreted, we developed cells in culture and assayed both cells and medium for DpoA activity. To assess the degree of enzyme leakage from within the cell, the experiment was carried out using cells transformed with the Escherichia coli LacZ gene, expressed from the actin 15 promoter. This allowed a comparison of the cytoplasmically expressed β-galactosidase activity with that of DpoA. The activity of both enzymes in the medium was~1% of the total ( Figure 4B ). This strongly suggests that DpoA activity is intracellular and that the small amount of extracellular activity is due to leakage from within cells plated under these conditions. The intracellular localization of DpoA activity is consistent with the cell-autonomous nature of the dpoA mutant observed in mixing experiments.
To investigate the subcellular localization of DpoA, cell extracts were made by filter lysis and differential centrifugation. DpoA activity was present in the supernatant following centrifugation at 100 000 g ( Figure 4C ), with only a trace activity (Ͻ0.1%) present in the low speed particulate fraction (P10 fraction). Very little crosscontamination was seen between membrane and cytosolic fractions. A similar cytoplasmic localization has been reported for POase enzymes of other species, including the human homologue (Kato et al., 1980) . Consistent with a cytosolic localization, no signal peptide sequence is present in DpoA or any other POase enzyme.
DpoA is not a Li ⍣ target
To establish a mechanism for Li ϩ resistance in the dpoA mutant, we examined the effect of Li ϩ on DpoA. Activity was tested in the presence of up to 30 mM LiCl and NaCl, but no effect on enzyme activity was observed in either salt ( Figure 5A ). This suggests that Li ϩ neither directly (C) Wild-type cells were lysed and fractionated to enrich for vacuole (P10), cell structural components (P100) and cytoplasmic proteins (S100). The total cell extract (CE) and each fraction was assayed for DpoA activity. To estimate the degree of separation, each sample was examined by Western blotting for cross-contamination with the endoplasmic reticulum-specific protein, protein disulfide isomerase (PDI; Monnat et al., 1997). activates nor inhibits DpoA. The effect of Li ϩ treatment on intact cells was also examined. Cells in shaking culture were treated with Li ϩ for 6 h and then extracts were tested for DpoA activity. No difference was seen in the level of activity in treated or non-treated samples ( Figure  5B ). As expected, no DpoA activity was seen in the dpoA mutant. We also observe no change of DpoA activity in wild-type cells after 6 h of development. These conditions are sufficient to induce csA expression, and we conclude, therefore, that DpoA activity is not regulated during early development. Our observations demonstrate that DpoA is not a direct target of Li ϩ and exclude the possibility that Li ϩ causes an increase of DpoA activity which then blocks development.
dpoA does not interact with gskA
GskA is inhibited by Li ϩ (Ryves et al., 1998) ; however, the biological effects of Li ϩ treatment on development are more severe than can be explained by a simple loss of GskA activity ( Figure 6A ). In particular, gskA mutant cells can aggregate in the absence of Li ϩ (Harwood et al., 1995) but, as seen with wild-type cells, are severely retarded in its presence ( Figure 6B ). As GskA protein is totally absent from the gskA mutant in this case, it cannot be the Li ϩ target. Introduction of the dpoA mutation into the gskA background confers Li ϩ resistance on the double mutant ( Figure 6C and D) . The fruiting body of the dpoA,gskA double mutant, however, retains the characteristic morphology of a small spore head and enlarged basal disc seen in a gskA mutant. This suggests that the dpoA mutation does not suppress the gskA mutant phenotype. Similarly, when the dpoA mutant is developed in the presence of 10 mM LiCl, it also has a smaller spore head and enlarged basal disc, suggesting that gskA is still a Li ϩ target in these cells ( Figure 1G ).
To verify these conclusions, we examined stalk cell differentiation in low density monolayer culture. Stalk cell differentiation is repressed by the presence of extracellular cAMP through a signal transduction pathway which requires gskA (Harwood et al., 1995) . The number of stalk cells formed in the presence of cAMP is therefore a sensitive indication of the activity of GskA and its associated signal transduction pathway. We find that cAMP strongly represses stalk cell differentiation of both wildtype and dpoA mutant cells ( Figure 6E ). No cAMP repression is seen with either gskA or double dpoA,gskA mutant cells. Addition of low concentrations (2.5 mM) of LiCl reverses the effects of cAMP on both wild-type and dpoA mutant cells. As we see no effect of 2.5 mM LiCl on the gskA mutant, we conclude that this effect is due to inhibition of GskA activity. The effect of LiCl on wildtype and dpoA mutant cells further demonstrates that Li ϩ ions enter the cell and target GskA. We can therefore find no evidence for an epistatic interaction between the dpoA and gskA genes, and all of our observations suggest that they are on different signal transduction pathways.
Loss of dpoA elevates IP 3 concentrations by dephosphorylation of IP 5 We investigated the possibility of an interaction between DpoA and phosphoinositide signalling. Treatment of Dictyostelium cells with 10 mM LiCl reduces the IP 3 concentration by 20% (Peters et al., 1989) . We compared the IP 3 concentration of wild-type and dpoA mutant cells during growth and development in shaking culture. The basal IP 3 concentration in dpoA mutant is 3-fold higher than in wild-type cells during the growth phase and continues to be higher during development ( Figure 7A ). The IP 3 concentration of dpoA mutant cells is sensitive to Li ϩ , but is still higher than in the wild-type after Li ϩ treatment. To confirm that the reduction of IP 3 concentration was due to inhibition of IMPase activity, wild-type cells were treated with Li ϩ in the presence of 10 mM myo-inositol. This restored cellular IP 3 concentrations to untreated levels ( Figure 7B ). These results suggest that loss of DpoA activity leads to an elevated concentration of IP 3 . To test this conclusion, wild-type cells were developed in the presence of the POase-specific inhibitor Z-Pro-L-prolinal dimethylacetal. This overcame the effect of Li ϩ and elevated IP 3 to a concentration higher than ever seen in untreated wild-type cells and matches that seen in the dpoA mutant ( Figure 7B ). We therefore conclude that the cellular IP 3 concentration is linked to DpoA activity and that the dpoA mutant is less sensitive to Li ϩ treatment as a consequence of its elevated IP 3 concentration. Treatment of wild-type cells with POase inhibitor had no effect on fruiting body formation even at concentrations 1000-fold higher than the K i (data not shown). This is expected as loss of dpoA has no obvious effect on morphogenesis in the absence of LiCl, and indicates that the effects of the POase inhibitor are likely to be specific to DpoA. To determine the cause of the increased IP 3 concentration in the dpoA mutant, we examined synthesis and degradation of IP 3 . The breakdown of PIP 2 to IP 3 was examined in membrane fractions prepared from wild-type and dpoA mutant cells by the method described by Bominaar and Van Haastert (1994) . This method assays the breakdown of endogenous PIP 2 by PLC and hence would be sensitive to changes in both PLC activity and PIP 2 concentration. We could detect no substantial differences in IP 3 synthesis between wild-type and dpoA mutant cells ( Figure 8A ). As PIP 2 hydrolysis is unaffected by the dpoA mutation, we examined whether a reduced rate of IP 3 degradation could account for the elevation in cellular IP 3 concentration. Extracts containing IP 3 phosphatase activity were prepared from both wild-type and dpoA mutant cells and the rate of breakdown of exogenous IP 3 was measured (Bominaar et al., 1991) . Rather than having reduced breakdown of IP 3 , degradation was increased in the dpoA mutant, giving a rate of 1.9 pmol/ min/mg of total protein for the dpoA mutant compared with 0.7 pmol/min/mg ( Figure 8B ). Whatever the cause of this increased activity, it cannot account for the elevated IP 3 levels present in the dpoA mutant. An alternative source of IP 3 has been reported in both mammalian cells and Dictyostelium. In this case, IP 3 can be formed by dephosphorylation of inositol (1,3,4,5,6) pentakisphosphate (IP 5 ) via inositol (1,4,5,6) and (1,3,4,5) tetrakisphosphate intermediates (Van Dijken et al., 1995a,b) . This enzyme activity was prepared from wild-type and dpoA mutant cells using the method described by Van Dijken and coworkers (1997), and the dephosphorylation of exogenous IP 5 was examined. In a 5 min time period, the dpoA mutant was found to synthesize 63% more IP 3 from IP 5 than wild-type cells, with a rate of~17 pmol/min/mg compared with 10 pmol/min/mg ( Figure 8C ). We therefore conclude that the elevated concentrations of IP 3 seen in dpoA mutant cells are due to increased dephosphorylation of IP 5 . . DpoA does not interact with the GSK-3 signalling pathway. Aggregation of a gskA mutant is not affected by 10 mM NaCl (A), but is impeded by 10 mM LiCl (B). The dpoA,gskA double mutant aggregates normally in the presence of 10 mM NaCl (C) and 10 mM LiCl (D). Bar ϭ 0.5 mm. (E) Monolayer analysis of wild-type, dpoA, gskA and dpoA,gskA cells (Harwood et al., 1995) . Cells were treated with cAMP or 2.5 mM LiCl as indicated. 
Discussion
Li ⍣ has multiple effects on Dictyostelium development Many of the effects of Li ϩ on Dictyostelium are consistent with its inhibition of GSK-3 activity. Li ϩ produces a patterning defect in which a disproportionate number of stalk cells are formed at the expense of spore cells (Maeda, 1970) . Li ϩ treatment can elevate expression of a pre-stalk enriched gene, cysteine proteinase-2, and reduce that of a pre-spore gene, PsA (Peters et al., 1989) . In this report, we show that Li ϩ treatment inhibits the repressive effects of cAMP on stalk cell differentiation in low density monolayer culture. These are all features consistent with a loss of GskA activity and this similarity is one of the factors which led Klein and Melton (1996) to consider Li ϩ as a GSK-3 inhibitor. It has been shown further that Li ϩ treatment can affect the Wnt-1 signalling pathway in a manner consistent with a reduction of GSK-3β activity (Stambolic et al., 1996; Hedgepeth et al., 1997) . In Dictyostelium, Li ϩ reverses the effects of loss of the cAMP receptor cAR4, an effect consistent with it acting through GskA (Ginsburg and Kimmel, 1997) .
Although inhibition of GSK-3 can explain the teratogenic activity of Li ϩ , it does not explain all of the biological effects of Li ϩ treatment on Dictyostelium development. Maeda (1970) describes a differential effect, where high Li ϩ concentrations block aggregation. Furthermore, the effects on gene expression observed by Peters and coworkers (1989) only occur at low Li ϩ concentrations, and at high concentrations all developmental gene expression was lost. We also observe an early developmental effect of Li ϩ , which in our conditions shows a severe retardation of aggregation and loss of expression of the aggregationspecific marker csA. Aggregation of the gskA mutant is also inhibited, indicating that in this case GskA is not the Li ϩ target. To identify the biologically relevant targets of Li ϩ , we isolated Li ϩ -resistant mutants. These fall into two groups: ones which affect stalk cell differentiation and hence could act through gskA (data not shown), and a second group in which cells overcome the effect of Li ϩ on aggregation. The dpoA mutant falls into this second group. We can find no genetic evidence for an epistatic interaction between dpoA and gskA and conclude that they lie on separate pathways. These results suggest that there are at least two separate targets of Li ϩ during Dictyostelium development, and the effect of Li ϩ described in earlier reports arises from the simultaneous inhibition of both.
As in previous reports, we find that Li ϩ treatment decreases the cellular IP 3 concentration, but this decrease is relatively small. This may be due to two distinct and Li ϩ -resistant IMPase activities that are also present in Dictyostelium cells (Van Dijken et al., 1996) . Accordingly, it has been suggested that IP 3 signalling is not a significant Li ϩ target in Dictyostelium. The failure to find a developmental phenotype associated with loss of the Dictyostelium PLC gene further strengthened this view (Drayer et al., 1994) although, in this case, IP 3 is generated by dephosphorylation of IP 5 (Van Dijken et al., 1997) . The discovery that elevated IP 3 confers Li ϩ resistance demonstrates that IP 3 signalling is a biologically significant target of Li ϩ and is required during early Dictyostelium development. Interestingly, cells appear largely unaffected by possession of a high cellular concentration of IP 3 , although they do show premature expression of the csA gene and are incapable of sustained growth in shaking culture.
A Dictyostelium prolyl oligopeptidase
The unique conformation of the prolyl bond protects peptides that contain proline residues from enzyme degradation, and many hormone and neuropeptides are enriched in proline residues. Prolyl oligopeptidases [EC 3.4.21.26] are endopeptidases that cleave Pro-X amino acid bonds, but are only active on polypeptides Ͻ3 kDa. They are required to degrade bioactive peptides (Cunningham and O'Connor, 1997) and in some cases to generate new signals, such as seen with the conversion of angiotensin I to angiotensin (1-7) and during host invasion by Trypanosoma cruzi (Burleigh et al., 1997) . POase enzymes are found in metazoa, protozoa and bacteria, but none have been found among the fungi and actinomycetes. The mammalian POase is found in all tissues, but is highly active within the brain, particularly in the frontal cortex, nucleus caudatus and amygdala (Kato et al., 1980; Goossens et al., 1997) . POase enzymes have been associated with neural processing, and POase inhibitors affect learning and memory (Toide et al., 1997) . It is interesting to note that these processes are attenuated by Li ϩ treatment (Barber et al., 1998; Cook and Persinger, 1998) . We have identified the first and probably only Dictyostelium member of this family and we have shown that DpoA has biochemical properties similar to those of other members of the group. The targets of DpoA are not known, although one candidate could be CMF, a protein factor which is processed into peptides and acts via PLC (Brazill et al., 1998) . CMF sensitizes cAMP receptors on the surface of developing Dictyostelium cells and is required for aggregation.
The known substrates of mammalian POase enzymes are extracellular signal peptides; it is therefore unexpected that POases are almost exclusively intracellular and are predominantly cytosolic (Kato et al., 1980) . Some activity has been found associated with synaptosomal membranes, although it is not clear whether this is the same POase present in the cytosol (O'Leary and O'Connor, 1995) . Significantly, only 0.1-1% of activity is found in serum (Kato et al., 1980) . We find DpoA is almost totally cytosolic, with Ͻ0.1% of activity present in the 10 000 g particulate fraction. We find only 1% of DpoA activity in the extracellular medium. This level of extracellular activity, however, is also seen for β-galactosidase, an enzyme that is definitively cytosolic, and is likely to arise from leakage of damaged cells. This creates a sensitivity limit for measurement of extracellular POase activity; however, our mixing experiments enable us to exclude the action of even undetectable levels of extracellular POase activity as mixing with small quantities of wild-type cells does not restore Li ϩ sensitivity to the dpoA mutant. As wildtype cells are not induced to aggregate in the presence of 10 mM LiCl when mixed with the dpoA mutant, we can also eliminate the possibility that the mutant overproduces an extracellular signal and escapes the inhibition by high levels of autocrine stimulation. There are two possibile mechanisms for the action of POases in the cytosol: they may either act on a peptide signal generated within the cell or they degrade extracellular peptides which function after import into the cell. Such a mechanism has been observed in the bacterium Bacillus subtilis where peptide signals are imported into the cell during regulation of sporulation (Lazazzera et al., 1997 ).
An association between prolyl oligopeptidase activity and IP 3 concentration
We have demonstrated an inverse relationship between POase activity and IP 3 concentration. This is seen either in a mutant which lacks all POase activity or in wild-type cells that are treated with a POase inhibitor. In both cases, basal concentrations of IP 3 increase to 3-4 times that seen in untreated wild-type cells. This relationship is unexpected and, to our knowledge, novel. To investigate further, we have examined the enzyme activities that generate or dephosphorylate IP 3 . The conventional mechanism of IP 3 production is via activation of PLC through activation of cell surface receptors by extracellular signals. We can exclude chronic stimulation of PLC in the dpoA mutant cells on two counts. First, the cytosolic localization of DpoA prevents it from acting on signal peptides outside the cell. Secondly, the rate of hydrolysis of PIP 2 in the dpoA mutant is the same as that seen in wild-type cells. We can also exclude the possibility that the higher cellular IP 3 concentration is due to decreased dephosphorylation, and in fact we find higher rates of IP 3 dephosphorylation in the dpoA mutant. This suggests a higher rate of phosphoinositide turnover in the absence of DpoA activity. IP 3 can also be generated by breakdown from the higher order phosphoinositides. This has been observed both in mammalian and Dictyostelium cells and involves enzyme activities which can dephosphorylate IP 5 , Ins(1,3,4,5)P 4 and Ins(1,4,5,6)P 4 to form IP 3 (Van Dijken et al., 1995b) . This could involve a single enzyme, multiple inositol polyphosphatase (MIPP), which removes phosphate from both the 6-and 3-positions (Shears, 1998) . This enzyme activity has been reported in AR4-2J pancreatoma cells, erthryocytes and liver cells (Estrada-Garcia et al., 1991; Nogimori et al., 1991; Oliver et al., 1992) . Curiously, enzyme purified from this last source appears to be compartmentalized to the lumen of the endoplasmic reticulum (ER) which would isolate it from its substrate (Ali et al, 1993) . MIPP has been cloned from these cells and contains a putative ER retention site, SDEL (Craxton et al., 1997; Caffrey et al., 1999) . In Dicytostelium, this enzyme activity is regulated by extracellular cAMP and can account for IP 3 production in the absence of PLC (Drayer et al., 1994) . We find that in the dpoA mutant the conversion of IP 5 to IP 3 is increased. We conclude that loss of DpoA activity causes enhanced turnover of phosphoinositides which has the effect of increasing the cellular concentration of IP 3 ( Figure 8D ). This would occur if the breakdown of IP 5 exceeds that of IP 3 , as reported in mammalian systems (Hughes et al., 1989) . Our results therefore demonstrate a novel mechanism to control the cellular IP 3 concentration.
POase activity and depression
Our observations link Li ϩ sensitivity, POase activity and the cellular IP 3 concentration to a single signal transduction pathway and have interesting implications for the Li ϩ treatment of depression. Recently, POase activity has been associated with the mental disorders of unipolar and bipolar depression. POase activity is lowered during depression, but raised during mania (Maes et al., 1994 (Maes et al., , 1995 , and antidepressant and antimanic drugs restore POase activity to normal levels (Maes et al., 1995) . Furthermore, POase is known to degrade Substance P, arginine, vasopressin, β-endorphin, thyroliberin and luliberin, all implicated in the pathophysiology of depression (Cunningham and O'Connor, 1997) . If the pathway we observe in Dictyostelium is conserved in the brain, it could explain the therapeutic effect of Li ϩ . Depression could result from a reduction in POase activity that leads to an elevated IP 3 concentration, which in turn is reversed by Li ϩ inhibition of IMPase and IPP. If this is the case, it provides support for the inositol depletion theory and suggests that IP 3 -, rather than GSK-3-mediated signal transduction is the appropriate target for the treatment of depression. Further insight into the nature of this signal transduction pathway will be obtained by examination of other Li ϩ -resistant mutants in this pathway.
Materials and methods
Materials
BOC-Glu(NHO-Bz)-Pyr was supplied by Calbiochem, Z-Pro-L-prolinal dimethylacetal and Z-Gly-Pro-pNA by Bachem (UK) Ltd, and myoinositol was supplied by Sigma-Aldrich Co. Ltd.
Cell culture and gene isolation
Cells were grown at 22°C in shaking culture (HL5 medium) up to 3ϫ10 6 cells/ml or in association with Klebsiella aerogenes. REMI mutagenesis was carried out using wild-type cells (Ax2) as previously described (Kuspa and Loomis, 1992) , and mutants were screened for the ability to aggregate and develop when grown on K.aerogenes in the presence of 10 mM LiCl. Li ϩ -resistant mutants were designated HAD170-HAD183. The dpoA mutant (HAD172) was recapitulated using 30 μg of rescued plasmid, cleaved with ClaI and reinserted into wild-type cells (Ax2) to give strains HAD200-HAD204, or into gskA mutant cells (HM1435) to give strain HAD205. The encoding cDNA was isolated from a slug stage cDNA library in λZAP (kindly provided by R.Firtel). Sequence analysis was performed by standard protocols using dRhodam-ine terminator cycle sequencing Ready Reactions (Applied Biosystems). The DDBJ/EMBL/GenBank accession Nos of the Dictyostelium dpoA gene and rescued fragment are AJ238018 and AJ238019, respectively. Developmental phenotypes were analysed by plating cells (density ϭ 1ϫ10 7 /filter) on 47 mm nitroclellulose filters (Millipore) soaked in KK 2 (16.5 mM KH 2 PO 4 , 3.8 mM K 2 HPO 4 pH 6.2) containing either 10 mM LiCl, 10 mM NaCl or 1.3 mM Z-Pro-L-prolinal dimethyacetal. Development was observed after 20 h unless otherwise stated. Staining for β-galactosidase was carried out as described in Dingermann et al. (1989) .
Immunological techniques
Extracts from 5ϫ10 5 cells were separated by SDS-PAGE and transferred to nitrocellulose (Hybond-C Extra, Amersham Pharmacia Biotech.) following standard procedures (Harlow and Lane, 1988) . csA and protein disulfide isomerase (PDI) proteins were detected by monoclonal antibody, mAb 33459 and mAb 221-135-1, respectively (kindly provided by J.Faix and M.Maniak) and visualized by chemiluminescence (Supersignal™, Pierce & Warriner Ltd). and dpoA cells were harvested and washed in KK 2 , and resuspended to give 2ϫ10 8 cells/ml in homogenization buffer [50 mM Tris pH 7.4, 1 mM EDTA, 1 mM dithiothreitol (DTT), 5 μg/μl aprotinin, 1 mM benzamidine, 10 μg/μl leupeptin, 0.1 mM TLCK]. Cells were lysed by sonication, and soluble fractions were prepared by centrifugation (100 000 g, 35 min, 4°C). Assays were measured in triplicate by combining 3 μl of enzyme extract with 300 μl of assay buffer [50 mM HEPES pH 7.8, 1 mM EDTA, 1 mM DTT, 0.25% dimethylsulfoxide (DMSO), 141 μM Z-Gly-Pro-pNA] and incubating at 37°C for 2 h. Units of enzyme activity were calculated from the increase in absorbance at 405 nm in 2 h (ε 405 ϭ 8800/M/cm; Mäkinen et al., 1994) , measured in triplicate using a microtitre plate reader. Standard Michaelis-Menten analysis of kinetic data was used to define enzymatic constants.
DpoA assays
Cell secretion assay
Actin15:LacZ-transformed wild-type (10 7 cells) were incubated in 10 ml of KK 2 in tissue culture plates. Cells were separated from medium by centrifugation. Filtered medium and the S100 cell fraction were assayed for POase activity and β-galactosidase activity according to Dingermann et al. (1989) .
DpoA localization
Wild-type cells (1.7ϫ10 8 ) were resuspended in 1.7 ml of KK 2 , diluted with 2 vols of homogenization buffer [30 mM Tris-HCl pH 7.4, 2 mM DTT, 4 mM EGTA, 2 mM EDTA, 5 mM benzamidine, 30% (w/v) sucrose] and lysed through a 5 μM nucleopore filter (Corning). Intact cells were removed by centrifugation at 750 g and the crude supernatant was centrifuged at 10 000 g to concentrate the particulate fraction (P10), and at 100 000 g to concentrate cell membrane and small vacuoles (P100). All pellets were washed in homogenization buffer and assayed for POase activity or for Western analysis with anti-DPI mAb (Monnat et al., 1997) .
Stalk cell induction assay
Cells were plated at a density of 10 5 cells/ml into stalk medium (10 mM MES, 2 mM NaCl, 10 mM KCl, 1 mM CaCl 2 , 200 μg/ml streptomycin, 20 μg/ml tetracycline; pH 6.2) supplemented with 5 mM cAMP. After 20 h, the medium was removed, the cells washed three times and replaced with fresh medium supplemented with 100 nM DIF (Berks and Kay, 1988) ; 5 mM cAMP and 2.5 mM LiCl were added as indicated. Stalk cells formed after a further 24 h.
IP 3 assays
Mutant and wild-type cells were grown in shaking culture overnight before assay. Cells were developed as shaking cultures (5 ϫ10 7 cells) in 1 ml of KK 2 at 22°C, 150 r.p.m. for 6 h. Aliquots of 200 μl were assayed for IP 3 concentration by an isotope dilution method (Amersham Pharmacia Biotech.), using final reaction volumes of 100 μl.
PLC hydrolysis, and IP 3 and IP 5 dephosphorylation assays Cell pellet and supernatant fractions were prepared from 2ϫ10 8 cells/ ml in buffer A [20 mM HEPES/NaOH pH 7, 0.5 mM EDTA, 200 mM sucrose (Van Dijken et al., 1996) ], lysed by passing through a 5 μm nucleopore membrane and separated by centrifugation at 100 000 g for 30 min. Pellets were washed and resuspended in equal volumes of buffer A. Bradford assays confirmed equal protein levels in extracts.
PLC and IP 5 dephosphorylation were measured by the production of IP 3 from pellet fractions at 22°C in the presence of 10 mM CaCl 2 and inhibitors of IP 3 breakdown, 25 mM LiCl and 250 μM diphosphoglycerate (Bominaar and Van Haastert, 1994; Van Dijken et al., 1997) . IP 5 (100 μM) (Sigma Chemical Co.) was added for the measurement of the conversion of IP 5 to IP 3 . IP 3 dephosphorylation was measured by the loss of IP 3 in supernatant fractions in the presence of 5 mM MgCl 2 (Bominaar et al., 1991) . In this assay, exogenous IP 3 was used to adjust the a final concentration to 200 μM. Figures represent average results from at least two independent extracts assayed twice in triplicate.
